Publication | Open Access

Effectiveness of BNT162b2 vaccine against SARS-CoV-2 infection and severe COVID-19 in children aged 5–11 years in Italy: a retrospective analysis of January–April, 2022

VaccinationVaccine SafetyBnt162b2 VaccineSars-cov-2 InfectionMedicineVaccine SurveillanceCovid-19 PandemicVaccine TestingRetrospective AnalysisVaccine EfficacyVaccine HesitancyPrecision VaccinologyEpidemiologyCovid-19